Trademark Alertz ®
Search
Trademark
Owner
Trademark: KRASLOQ 2164620
Word
KRASLOQ
ID
2164620
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
18 March 2021
Registration Date
18 March 2021
Renewal Date
18 March 2031
Owner(s)
Mirati Therapeutics, Inc A Delaware corporation
Service
Knightsbridge Patent Attorneys
Goods and Services:
Class 5
:
Pharmaceuticals
;
pharmaceutical preparations
;
pharmaceutical products
;
pharmaceutical preparations for the treatment of cancer
;
pharmaceutical preparations for use in oncology
;
pharmaceutical preparations for the treatment of infectious diseases
;
pharmaceutical preparations for the treatment of lung cancer
;
pharmaceutical preparations for the treatment of non-small cell lung carcinoma
;
pharmaceutical preparations for the treatment of colorectal carcinoma
;
pharmaceutical preparations for the treatment of pancreatic cancer
;
pharmaceuticals comprising small molecules
;
pharmaceuticals comprising small molecules for the treatment of cancer
;
pharmaceuticals comprising small molecules for the treatment of infectious diseases
;
pharmaceuticals comprising small molecules for the treatment of lung cancer
;
pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma
;
pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma
;
pharmaceuticals comprising small molecules for the treatment of pancreatic cancer
;
pharmaceuticals comprising compounds
;
pharmaceuticals comprising compounds for the treatment of cancer
;
pharmaceuticals comprising inhibitors
;
pharmaceuticals comprising inhibitors for the treatment of cancer
;
pharmaceuticals for the treatment of solid tumors
;
pharmaceuticals for the treatment of advanced solid tumors
;
Pharmaceutical formulations, including pharmaceutical formulations for the treatment of cancer or infectious diseases, pharmaceutical formulations comprising small molecules, and pharmaceutical formulations comprising inhibitors
Class 42
:
Research and development of pharmaceuticals in the field of oncology
;
providing information in the field of scientific and medical research related to oncology
;
research and development of pharmaceuticals
;
providing information in the field of scientific and medical research related to pharmaceuticals
;
Pharmaceutical research and development services, including conducting pharmaceutical research and/or development on behalf of others
;
medical and scientific research relating to pharmaceuticals, including conducting clinical trials on behalf of others
;
the provision of any one or more of these services (including one or more aspects of them) on-line, including via a global communications or telecommunications network, such as the Internet